Enteral Feeding Devices Market Size, Share, and Trends 2024 to 2034

The global enteral feeding devices market size was USD 4.50 billion in 2023, estimated at USD 4.73 billion in 2024 and is anticipated to reach around USD 7.67 billion by 2034, expanding at a CAGR of 4.95% from 2024 to 2034.

  • Last Updated : August 2024
  • Report Code : 1226
  • Category : Healthcare

Enteral Feeding Devices Market Size and Growth 2024 to 2034

The global enteral feeding devices market size accounted for USD 4.73 billion in 2024 and is predicted to reach around USD 7.67 billion by 2034, growing at a CAGR of 4.95% from 2024 to 2034.

Enteral Feeding Devices Market Size 2024 To 2034

Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare


Enteral Feeding Devices Market Key Takeaways

  • North America led the global market with the highest market share in 2023.
  • The enteral feeding pump segment claimed the leading market stake in 2023.
  • By Application, the rising influence of cancer is set to lead to generating revenue within the enteral feeding devices market.
  • By End-User, Hospitals played a dominant role in driving revenue within the enteral feeding devices.

Market Overview

Enteral feeding devices are medical devices used to deliver liquid nutrition directly to the stomach or intestines of those people who are unable to consume food orally due to some medical conditions or swallowing difficulties. Enteral feeding devices include feeding pumps, flexible tubes, and syringes. These devices help to administer liquid nutrition, medications, and supplements. These devices are placed through the nose or mouth or surgically implanted into the stomach. The global enteral feeding devices market has registered a significant growth over the years. There has been a significant increase in the demand for enteral feeding devices during the COVID-19 pandemic due to a large number of people requiring nutritional support, particularly those affected by COVID-19. 

U.S. Enteral Feeding Devices Market Size and Growth 2024 To 2034

The U.S. enteral feeding devices market size was valued at USD 1.20 billion in 2023 and is expected to be worth USD 2.06 billion by 2034, growing at a CAGR of 5.03% between 2024 and 2034.

U.S. Enteral Feeding Devices Market Size 2024 To 2034

 North America held the largest share of the market in 2023 due to the increasing health awareness, rising geriatric population, and rising healthcare expenditure, which supports the adoption of advanced medical devices such as enteral feeding devices. Moreover, a significant growth in premature births in the U.S. contributed to the market growth. As premature birth increases, the demand for pediatric enteral feeding devices increases, which is vital in delivering essential nutrition to premature babies.

Enteral Feeding Devices Market  Share, By Region, 2023 (%)

As per the Population Reference Bureau, the number of Americans ages 65 or above is anticipated to increase from 58 million in 2022 to 82 million by 2050, a 47% increase.

According to the National Center for Health Statistics (NCHS), the rate of premature birth in the U.S. grew 12% from 2014 to 2022.

The market in Asia Pacific is anticipated to expand at the fastest CAGR during the forecast period due to the high prevalence of chronic diseases, such as diabetes, cancer, and chronic kidney disease (CKD). These diseases often require enteral feeding devices for dietary management. Furthermore, the growing geriatric population in countries such as India and Japan is projected to boost market growth.

Elderly Population Growth in India

Enteral Feeding Devices Market Growth Factors

The market is expected to grow rapidly in the coming years due to the increasing advancements in medical devices and the growing elderly population. Conditions such as dysphagia, dementia, and gastrointestinal disorders are common among elderly people. These conditions may sometimes lead to swallowing difficulties. As people age, they require nutritional support. Thus, the growing elderly population significantly fuels the market. For instance,

According to the World Health Organization (WHO), the number of people aged 60 years or older is projected to increase from 1 billion in 2020 to 2.1 billion by 2050. The number of people aged 80 years or older is projected to triple between 2020 and 2050 to reach 426 million.

Market Scope

Report Highlights Details
Market Size by 2034 USD 75.45 Billion
Market Size in 2023 USD 28.86 Billion
Market Size in 2024 USD 31.49 Billion
Market Growth Rate from 2024 to 2034 CAGR of 9.13%
Base Year 2023
Forecast Period 2024 to 2034
Segments Covered Age Group, Product, Application, End User, and Region
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA)


Market Dynamics

Major Drivers

Prevalence of Chronic Diseases and Rising Number of Surgeries

The growing prevalence of chronic diseases across the globe is expected to drive the market during the forecast period. Chronic diseases such as diabetes, cancer, chronic kidney disease (CKD), and Alzheimer’s disease often cause serious problems, such as swallowing difficulty. However, proper nutrition is important in many chronic diseases, preventing complications and improving health outcomes. Thus, as the number of patients with these conditions increases, so does the need for nutritional support, which significantly boosts the market.

As per the National Library of Medicine, about one in three adults worldwide suffer from multiple chronic conditions (MCCs).

Furthermore, the rising number of surgical procedures is expected to drive the market. Surgical procedures often cause difficulties with oral intake after surgery due to pain or reduced appetite. However, enteral feeding devices play a vital role in delivering essential nutrition to patients recovering from surgical interventions, promoting faster recovery.

According to the National Institute of Health (NIH), around 310 million major surgeries are performed worldwide every year.

Existing Restraints

Lack of awareness

The lack of awareness about the benefits and usage of enteral feeding devices among patients in underdeveloped regions hamper the market. If patients are unaware of the benefits of these devices in managing chronic conditions, their use becomes limited. Moreover, the lack of reimbursement policies for these devices deters some patients from adopting them.

Emerging Opportunities

Technological Advancements

The rising technological advancements in medical devices create lucrative opportunities in the market. Advancements in enteral feeding devices lead to user-friendly and portable devices, making them suitable for home care. Implementing real-time monitoring with these devices helps provide doctors with useful data about patient nutrition and feeding. Furthermore, the rising trend of self-medication and self-care propels the demand for these advanced devices.

Product Type Insights

The enteral feeding pump segment held a large share of the market in 2023. The segment growth is mainly attributed to the rising concern about overfeeding. Enteral feeding pumps offer accurate control over nutrition given to patients, guaranteeing precise delivery of nutrients or medications. This precision helps to prevent overfeeding, which may lead to complications. However, this accuracy is crucial in cancer treatment, as inaccurate nutrition levels may lead to complications that impede treatment effectiveness. These pumps offer flexibility to combine methods such as continuous feeding overnight and bolus feeding during the day to make the feeding process more tailored to the patient’s condition.

The enteral feeding tube segment is projected to grow rapidly during the forecast period. Enteral feeding tubes are available in a range of sizes. They are either inserted through the mouth or through the nose into the stomach. These tubes can be customized according to the patient’s needs and can also be used to remove stomach contents.

Age Group Insights

The adults segment held a major share of the market in 2023 due to the growing prevalence of age-related diseases, such as diabetes, dementia, chronic obstructive pulmonary disease, and gastrointestinal disorders. Moreover, the increasing instances of dysphagia in adults contributed to the segmental growth. Enteral feeding devices are required to supply nutritional supplements to people suffering from these ailments. For instance,

According to the National Institute of Health (NIH), dysphagia is common in adults. About 1 in 6 adults experience difficulty in swallowing.

The pediatrics segment is expected to register a significant growth rate in the coming. There has been a significant growth in the occurrence of malnutrition among children. This, in turn, boosts the demand for enteral feeding devices that are designed for infants, such as nasojejunal tubes, G-tubes, and jejunostomy tubes. As per the World Health Organization (WHO), around half of deaths among children under 5 years of age are linked to undernutrition. Moreover, the increasing instances of premature birth are expected to boost the segment. For instance,

According to the National Library of Medicine, over 400,000 babies are born prematurely every year in the U.S.

Application Insights

The cancer segment dominated the market in 2023. The segment is anticipated to expand at the fastest CAGR during the forecast period due to the rising cancer cases worldwide. Cancer treatment, such as chemotherapy and radiation therapy, often creates mouth sores or swallowing difficulties. This boosts the need for reliable solutions for delivering medications and nutrients to patients with such conditions, thereby driving the demand for enteral feeding devices. For instance,

As per the World Health Organization (WHO), nearly 20 million new cancer cases and 9.7 million cancer deaths were recorded worldwide in 2022. About 1 in 5 people develop cancer in their lifetime, and about 1 in 12 women and 1 in 9 men die from cancer.

End-user Insights

The hospitals segment held a major share of the market in the enteral feeding devices market in 2023 due to the rising number of patients in hospitals requiring nutrition support. Moreover, factors such as easy accessibility to advanced medical devices, availability of skilled healthcare professionals, and the rising number of ICU admissions contributed to the market growth

Enteral Feeding Devices Market Companies

Leading competitors contending in the global enteral feeding devices market are as follows:

  • Cook Medical
  • Abott Laboratories
  • Fresenius Kabi
  • Halyard Health
  • Medtronic
  • Moog, Inc
  • Nestle Health Science
  • VYGON
  • Danone
  • Cardinal Health
  • Braun
  • Boston Scientific
  • R. Bard
  • Conmed Corporation

Recent Developments

  • In July 2024, Amsino Medical Group Company (Amsino), a leading provider of medical consumable devices, acquired Alcor Scientific’s enteral feeding pump products. The acquisition allows Amsino to broaden its portfolio of enteral feeding devices with Alcor Scientific.
  • In August 2023, Cardinal Health launched its next generation NTrainer System 2.0, a medical device designed to help premature and newborn infants develop the oral coordination skills to transition to independent feeding faster, thereby reducing their neonatal intensive care unit (NICU) stay. Through real-time assessment technology, the NTrainer System offers clinicians the objective data necessary to track the infant’s progress in developing pre-feeding skills.

Major Market Segments Covered:

By Product Type

  • Administration Sets
  • Enteral Feeding Pump
  • Enteral Syringe
  • Enteral Feeding Tube
  • Others

By Age Group

  • Pediatrics
  • Adult

By Application

  • Gastrointestinal Disease
  • Cancer
  • Malnutrition
  • Neurological Disorder
  • Others

By End User

  • Ambulatory Surgical Center (ASCs)
  • Hospital
  • Home Care
  • Others

By Geography

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa (MEA)

Frequently Asked Questions

According to Precedence Research, the global enteral feeding devices market size was valued at USD 4.50 billion in 2023 is anticipated to reach USD 7.67 billion by 2034.

An enteral feeding device can be described as a medical device that is used to transport nutrition to individuals who cannot gain nutrition through mouth and are incapable of swallowing securely, or require enteral feeding devices.

The global enteral feeding devices market is exhibiting CAGR of 4.95% during the estimate period 2024 to 2034.

Integration of safety and programming features within the feeding devices, development of portable feeding devices, growing number of preterm child birth, increasing healthcare expenditure, and increasing geriatric population are among major factors boosting growth of the global industry. Additionally, increasing prevalence of chronic ailments such as cancer and diabetes is fueling growth of the enteral feeding devices market worldwide. Moreover, rapidly increasing awareness regarding enteral feeding is having positive impact on the growth of global industry. Further, increased focus on the improvement of healthcare infrastructure in developing regions and growing investment by major market players on research and development are other factors to boost growth of the global market during th

The enteral feeding pump segment displayed a major share in the worldwide enteral feeding devices market in 2023. Technological advancements in the feeding pumps are expected to boost the growth of the segment in the near future.

By region, enteral feeding devices market is led by North America due to higher healthcare spending, presence of modern healthcare set-up, and availability of latest products.

The major companies functioning in the worldwide enteral feeding devices are Cook Medical, Abott Laboratories, Fresenius Kabi, Halyard Health, Medtronic, Moog, Inc, Nestle Health Science, VYGON, Danone, Cardinal Health, B.Braun, Boston Scientific, C.R. Bard, and Conmed Corporation among others.

Asia Pacific is anticipated to grow at the fastest CAGR majorly due to increasing incidence of cancer and gastrointestinal ailments, high rate of preterm child birth, and increasing number of hospital admissions.

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Enteral Feeding Devices Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope

Chapter 5. COVID 19 Impact on Enteral Feeding Devices Market

5.1. Covid-19: Enteral Feeding Devices Industry Impact
5.2. Enteral Feeding Devices Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and Enteral Feeding Devices Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Enteral Feeding Devices Market Players to deal with Covid-19 Pandemic Scenario

Chapter 6. Enteral Feeding Devices Market Dynamics Analysis and Trends

6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Integration of safety and programming features within the feeding devices
6.1.1.2. Development of portable feeding devices
6.1.2. Market Restraints
6.1.2.1. Complications associated with enteral feeding devices
6.1.3. Market Opportunities
6.1.3.1. Rapidly increasing awareness regarding enteral feeding
6.1.3.2. Increased focus on the improvement of healthcare infrastructure

Chapter 7. Global Enteral Feeding Devices Market: Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Enteral Feeding Devices Market Revenue by Market Players
7.1.1.2. Enteral Feeding Devices Market Revenue Market Share by Market Players
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of End-users

Chapter 8. Global Enteral Feeding Devices Market, By Product Type

8.1. Enteral Feeding Devices Market, by Product Type, 2024-2034
8.1.1. Administration Sets
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Enteral Feeding Pump
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Enteral Syringe
8.1.3.1. Market Revenue and Forecast (2021-2034)
8.1.4. Enteral Feeding Tube
8.1.4.1. Market Revenue and Forecast (2021-2034)
8.1.5. Others
8.1.5.1. Market Revenue and Forecast (2021-2034)

Chapter 9. Global Enteral Feeding Devices Market, By Application

9.1. Enteral Feeding Devices Market, by Application, 2024-2034
9.1.1. Gastrointestinal Disease
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Cancer
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Malnutrition
9.1.3.1. Market Revenue and Forecast (2021-2034)
9.1.4. Neurological Disorder
9.1.4.1. Market Revenue and Forecast (2021-2034)
9.1.5. Others
9.1.5.1. Market Revenue and Forecast (2021-2034)

Chapter 10. Global Enteral Feeding Devices Market, By Age Group

10.1. Enteral Feeding Devices Market, by Age Group, 2021-2034
10.1.1. Pediatrics
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Adult
10.1.2.1. Market Revenue and Forecast (2021-2034)

Chapter 11. Global Enteral Feeding Devices Market, By End-User

11.1. Enteral Feeding Devices Market, by End User, 2024-2034
11.1.1. Gastrointestinal Disease
11.1.1.1. Market Revenue and Forecast (2021-2034)
11.1.2. Cancer
11.1.2.1. Market Revenue and Forecast (2021-2034)
11.1.3. Malnutrition
11.1.3.1. Market Revenue and Forecast (2021-2034)
11.1.4. Neurological Disorder
11.1.4.1. Market Revenue and Forecast (2021-2034)
11.1.5. Others
11.1.5.1. Market Revenue and Forecast (2021-2034)

Chapter 12. Global Enteral Feeding Devices Market, Regional Estimates and Trend Forecast

12.1. North America
12.1.1. Market Revenue Forecast by Product Type(2021-2034)
12.1.2. Market Revenue Forecast by Application (2021-2034)
12.1.3. Market Revenue Forecast by Age Group (2021-2034)
12.1.4. Market Revenue Forecast by End User (2021-2034)
12.1.5. U.S
12.1.5.1. Market Revenue Forecast (2021-2034)
12.1.6. Canada
12.1.6.1. Market Revenue Forecast (2021-2034)
12.2. Europe
12.2.1. Market Revenue Forecast by Product Type (2021-2034)
12.2.2. Market Revenue Forecast by Application (2021-2034)
12.2.3. Market Revenue Forecast by Age Group (2021-2034)
12.2.4. Market Revenue Forecast by End User (2021-2034)
12.2.5. UK
12.2.5.1. Market Revenue Forecast (2021-2034)
12.2.6. Germany
12.2.6.1. Market Revenue Forecast (2021-2034)
12.2.7. France
12.2.7.1. Market Revenue Forecast (2021-2034)
12.2.8. Rest of EU
12.2.8.1. Market Revenue Forecast (2021-2034)
12.3. Asia Pacific (APAC)
12.3.1. Market Revenue Forecast by Product Type (2021-2034)
12.3.2. Market Revenue Forecast by Application (2021-2034)
12.3.3. Market Revenue Forecast by Age Group (2021-2034)
12.3.4. Market Revenue Forecast by End User (2021-2034)
12.3.5. China
12.3.5.1. Market Revenue Forecast (2021-2034)
12.3.6. India
12.3.6.1. Market Revenue Forecast (2021-2034)
12.3.7. Japan
12.3.7.1. Market Revenue Forecast (2021-2034)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue Forecast (2021-2034)
12.4. LATAM
12.4.1. Market Revenue Forecast by Product Type (2021-2034)
12.4.2. Market Revenue Forecast by Application (2021-2034)
12.4.3. Market Revenue Forecast by Age Group (2021-2034)
12.4.4. Market Revenue Forecast by End User (2021-2034)
12.4.5. Brazil
12.4.5.1. Market Revenue Forecast (2021-2034)
12.4.6. Rest of LATAM
12.4.6.1. Market Revenue Forecast (2021-2034)
12.5. Middle East and Africa (MEA)
12.5.1. Market Revenue Forecast by Product Type (2021-2034)
12.5.2. Market Revenue Forecast by Application (2021-2034)
12.5.3. Market Revenue Forecast by Age Group (2021-2034)
12.5.4. Market Revenue Forecast by End User (2021-2034)
12.5.5. GCC
12.5.5.1. Market Revenue Forecast (2021-2034)
12.5.6. North Africa
12.5.6.1. Market Revenue Forecast (2021-2034)
12.5.7. South Africa
12.5.7.1. Market Revenue Forecast (2021-2034)
12.5.8. Rest of MEA
12.5.8.1. Market Revenue Forecast (2021-2034)

Chapter 13. Company Profiles

13.1. Cook Medical
13.1.1. Company Overview, Business Information, Regional Presence
13.1.2. Product Portfolio Analysis
13.1.2.1. Product Details, Specification, Application
13.1.3. Revenue, Price, and Gross Margin
13.1.4. Recent Developments and Strategies
13.2. Abott Laboratories
13.2.1. Company Overview, Business Information, Regional Presence
13.2.2. Product Portfolio Analysis
13.2.2.1. Product Details, Specification, Application
13.2.3. Revenue, Price, and Gross Margin
13.2.4. Recent Developments and Strategies
13.3. Fresenius Kabi
13.3.1. Company Overview, Business Information, Regional Presence
13.3.2. Product Portfolio Analysis
13.3.2.1. Product Details, Specification, Application
13.3.3. Revenue, Price, and Gross Margin
13.3.4. Recent Developments and Strategies
13.4. Halyard Health
13.4.1. Company Overview, Business Information, Regional Presence
13.4.2. Product Portfolio Analysis
13.4.2.1. Product Details, Specification, Application
13.4.3. Revenue, Price, and Gross Margin
13.4.4. Recent Developments and Strategies
13.5. Medtronic
13.5.1. Company Overview, Business Information, Regional Presence
13.5.2. Product Portfolio Analysis
13.5.2.1. Product Details, Specification, Application
13.5.3. Revenue, Price, and Gross Margin
13.5.4. Recent Developments and Strategies
13.6. Moog, Inc
13.6.1. Company Overview, Business Information, Regional Presence
13.6.2. Product Portfolio Analysis
13.6.2.1. Product Details, Specification, Application
13.6.3. Revenue, Price, and Gross Margin
13.6.4. Recent Developments and Strategies
13.7. Nestle Health Science
13.7.1. Company Overview, Business Information, Regional Presence
13.7.2. Product Portfolio Analysis
13.7.2.1. Product Details, Specification, Application
13.7.3. Revenue, Price, and Gross Margin
13.7.4. Recent Developments and Strategies
13.8. VYGON
13.8.1. Company Overview, Business Information, Regional Presence
13.8.2. Product Portfolio Analysis
13.8.2.1. Product Details, Specification, Application
13.8.3. Revenue, Price, and Gross Margin
13.8.4. Recent Developments and Strategies
13.9. Danone
13.9.1. Company Overview, Business Information, Regional Presence
13.9.2. Product Portfolio Analysis
13.9.2.1. Product Details, Specification, Application
13.9.3. Revenue, Price, and Gross Margin
13.9.4. Recent Developments and Strategies
13.10. Cardinal Health
13.10.1. Company Overview, Business Information, Regional Presence
13.10.2. Product Portfolio Analysis
13.10.2.1. Product Details, Specification, Application
13.10.3. Revenue, Price, and Gross Margin
13.10.4. Recent Developments and Strategies
13.11. B.Braun
13.11.1. Company Overview, Business Information, Regional Presence
13.11.2. Product Portfolio Analysis
13.11.2.1. Product Details, Specification, Application
13.11.3. Revenue, Price, and Gross Margin
13.11.4. Recent Developments and Strategies
13.12. Boston Scientific
13.12.1. Company Overview, Business Information, Regional Presence
13.12.2. Product Portfolio Analysis
13.12.2.1. Product Details, Specification, Application
13.12.3. Revenue, Price, and Gross Margin
13.12.4. Recent Developments and Strategies
13.13. C.R. Bard
13.13.1. Company Overview, Business Information, Regional Presence
13.13.2. Product Portfolio Analysis
13.13.2.1. Product Details, Specification, Application
13.13.3. Revenue, Price, and Gross Margin
13.13.4. Recent Developments and Strategies
13.14. Conmed Corporation
13.14.1. Company Overview, Business Information, Regional Presence
13.14.2. Product Portfolio Analysis
13.14.2.1. Product Details, Specification, Application
13.14.3. Revenue, Price, and Gross Margin
13.14.4. Recent Developments and Strategies

Chapter 14. Appendix

 14.1. About Us
14.2. Glossary of Terms

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client